|
1
|
Fujita M, Yamaguchi R, Hasegawa T, Shimada
S, Arihiro K, Hayashi S, Maejima K, Nakano K, Fujimoto A, Ono A, et
al: Classification of primary liver cancer with immunosuppression
mechanisms and correlation with genomic alterations. Ebiomedicine.
53:1026592020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang SJ, Chao D, Wei W, Nan G, Li JY, Liu
FL, Li L, Jiang JL, Cui HY and Chen ZN: CD147 promotes collective
invasion through cathepsin B in hepatocellular carcinoma. J Exp
Clin Cancer Res. 39:1452020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Q, Chen WW, Sun X, Qian D, Tang DD,
Zhang LL, Li MY, Wang LY, Wu CJ and Peng W: The versatile emodin: A
natural easily acquired anthraquinone possesses promising
anticancer properties against a variety of cancers. Int J Biol Sci.
18:3498–3527. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou Z, Li Y, Hao H, Wang Y, Zhou Z, Wang
Z and Chu X: Screening hub genes as prognostic biomarkers of
hepatocellular carcinoma by bioinformatics analysis. Cell
Transplant. 28 (1 Suppl):76S–86S. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng L, Wei Y and Xiao Y:
Chemo-immunoablation of solid tumors: A new concept in tumor
ablation. Front Immunol. 13:10575352023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu J, Cheng ZG, Han ZY, Liu FY, Zheng RQ,
Cheng W, Wei Q, Yu SY, Li QY, He GZ, et al: Period-dependent
survival benefit of percutaneous microwave ablation for
hepatocellular carcinoma: A 12-year real-world, multicentric
experience. Liver Cancer. 11:341–353. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ozen M and Raissi D: Editorial comment: A
review on radiofrequency, microwave and high-intensity focused
ultrasound ablations for hepatocellular carcinoma with cirrhosis.
Hepatobiliary Surg Nutr. 11:453–456. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van de Berg NJ, Meeuwsen FC, Doukas M,
Kronreif G, Moelker A and van den Dobbelsteen JJ: Steerable needles
for radio-frequency ablation in cirrhotic livers. Sci Rep.
11:3092021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tay BWR, Huang DQ, Mark M, Thong NW, Guan
HL, Gee LS, Cheng LH, Mei LY, Thurairajah P, Chen LJ, et al:
Comparable outcomes in early hepatocellular carcinomas treated with
trans-arterial chemoembolization and radiofrequency ablation.
Biomedicines. 10:23612022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li B, Liu C, Xu XX, Li Y, Du Y, Zhang C,
Zheng HJ and Yang HF: Clinical application of artificial ascites in
assisting CT-guided percutaneous cryoablation of hepatic tumors
adjacent to the gastrointestinal tract. Sci Rep. 7:166892017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chu MO, Shen CH, Chang TS, Xu HW, Yen CW,
Lu SN and Hung CH: Pretreatment inflammation-based markers predict
survival outcomes in patients with early stage hepatocellular
carcinoma after radiofrequency ablation. Sci Rep. 8:166112018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yun J, Lee YJ, Kang K and Park J:
Effectiveness of SBAR-based simulation programs for nursing
students: A systematic review. BMC Med Educ. 23:5072023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan Z, Zhou P, Jin B, Li G, Feng L, Zhuang
C and Wang S: Recent therapeutics in hepatocellular carcinoma. Am J
Cancer Res. 13:261–275. 2023.PubMed/NCBI
|
|
14
|
Adnan A, Muñoz NM, Prakash P, Habibollahi
P, Cressman ENK and Sheth RA: Hyperthermia and tumor immunity.
Cancers (Basel). 13:25072021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Q, Li J, Zeng Q, Tan L, Zheng R, He
X and Li K: Value of artificial ascites to assist thermal ablation
of liver cancer adjacent to the gastrointestinal tract in patients
with previous abdominal surgery. BMC Cancer. 20:7632020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang CC and Kao JH: Artificial ascites is
feasible and effective for difficult-to-ablate hepatocellular
carcinoma. Hepatol Int. 9:514–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishimura M, Nouso K, Kariyama K, Wakuta
A, Kishida M, Wada N, Higashi T and Yamamoto K: Safety and efficacy
of radiofrequency ablation with artificial ascites for
hepatocellular carcinoma. Acta Med Okayama. 66:279–284.
2012.PubMed/NCBI
|
|
18
|
Song SG, Hur YH, Cho JY, Shin MH, Yoon EJ
and Kim JW: Pleural effusion after hepatic radiofrequency ablation
with artificial ascites: Clinical spectrum and significance. J Vasc
Interv Radiol. 31:1636–1644.e1. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Wang J, Li H, Zheng T, Jiang H,
Li M and Song B: Performance of LI-RADS version 2018 CT treatment
response algorithm in tumor response evaluation and survival
prediction of patients with single hepatocellular carcinoma after
radiofrequency ablation. Ann Transl Med. 8:3882020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SJ, Lee DH and Han JK: Reducing pain
by artificial ascites infusion during radiofrequency ablation for
subcapsular hepatocellular carcinoma. Cardiovasc Intervent Radiol.
44:565–573. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berghi ON, Dumitru M, Vrinceanu D, Cergan
R, Jeican II, Giurcaneanu C and Miron A: Current approach to
medico-legal aspects of allergic reactions. Rom J Leg Med.
29:328–331. 2021. View Article : Google Scholar
|
|
22
|
Jiang C, Liu B, Chen S, Peng Z, Xie X and
Kuang M: Safety margin after radiofrequency ablation of
hepatocellular carcinoma: precise assessment with a
three-dimensional reconstruction technique using CT imaging. Int J
Hyperthermia. 34:1135–1141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan Y, Li Y, Yang G, Zhang L and Ye J:
Effect of Comprehensive nursing approach in perioperative stage of
patients with hepatocellular carcinoma interventional therapy. Evid
Based Complement Alternat Med. 2022:68624632022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Melliza DM and Woodall M: Radiofrequency
ablation of liver tumors: The complementary roles of the clinic and
research nurse. Gastroenterol Nurs. 23:210–214. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Yang Y, Liu W, Yuan B, Tao C and
Dou G: Effects of nursing care using a fast-track surgery approach
in 49 patients with early-stage hepatocellular carcinoma undergoing
first-line treatment with radiofrequency ablation: A retrospective
study. Med Sci Monit. 29:e9390442023. View Article : Google Scholar : PubMed/NCBI
|
